{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:19:03Z","timestamp":1763641143683},"reference-count":27,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim: <\/jats:bold> The aim of the study was to review all cases of <jats:italic>Pneumocystis carinii <\/jats:italic>pneumonia (PCP) in patients seen by the Christchurch Hospital Rheumatology service over a 5\u2010year period and to determine the annual incidence of PCP.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> The Canterbury Health Laboratory database was searched for rheumatology patients testing positive for PCP from 31 December 2000 to 31 December 2005. The rheumatology database was then searched to identify patients receiving the same immunosuppressant medication as those who developed PCP to determine the annual incidence of PCP in this group.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Four rheumatology patients were diagnosed with PCP during the 5\u2010year period. Two were receiving oral methotrexate (MTX) for rheumatoid arthritis and two were receiving cyclophosphamide (CYC), one each for Wegener\u2019s granulomatosis and dermatomyositis. None of the four cases was receiving PCP chemoprophylaxis. Five hundred and forty\u2010seven patients commenced MTX over the same 5\u2010year period and 47 commenced CYC. Only 14 of 47 (29.7%) CYC\u2010treated patients received PCP prophylaxis. The annual incidence of PCP was 0.17% (95% confidence interval (CI) 0.02\u20130.63) and 5.33% (95%CI 0.65\u201319.24) in patients prescribed MTX and CYC, respectively. For the 33 patients receiving CYC without concomitant PCP prophylaxis the annual incidence was 9.50% (95%CI 1.15\u201334.33).<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> In our study the annual incidence of PCP in patients taking MTX was low and would not support the use of routine PCP chemoprophylaxis. In patients receiving CYC without concomitant PCP chemoprophylaxis the annual incidence of PCP was higher although the number of cases was small. Given the high morbidity and mortality in this group, PCP chemoprophylaxis should be considered.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2007.01382.x","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T08:01:13Z","timestamp":1179734473000},"page":"687-692","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5\u2010year period"],"prefix":"10.1111","volume":"37","author":[{"given":"K.","family":"Meuli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/339548"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002"},{"issue":"4","key":"e_1_2_6_4_2","first-page":"1","article-title":"Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus","volume":"41","author":"Centers for Disease Control","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001183220304"},{"key":"e_1_2_6_6_2","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau B","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.3.7881673"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025760"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.3.205"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg263"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.8.951"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.12.991"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000221794.24431.36"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.4065\/71.1.5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.133.5.2502","article-title":"Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia","volume":"133","author":"Walzer P","year":"1984","journal-title":"J Immunol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.3.712"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00004"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2005.73.58","article-title":"Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use","volume":"73","author":"Mwamburi D","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197712292972602"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archinte.1991.00400040042010","article-title":"Low\u2010dose intermittent trimethoprim\u2010sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection","volume":"151","author":"Wormser G","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03720080019021"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93402-U"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350103"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.770-782.2004"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00077-9"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb139873.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-4-42"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2007.01382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2007.01382.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:09:36Z","timestamp":1696903776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2007.01382.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,21]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1445-5994.2007.01382.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2007.01382.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,21]]},"assertion":[{"value":"2007-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}